{"id":"W4212945886","doi":"10.17925/usn.2021.17.2.70","title":"Innovative Therapeutic Development Programme for the Treatment of Early Alzheimer's Disease: Lecanemab (BAN2401)","year":2021,"lang":"en","type":"article","venue":"touchREVIEWS in Neurology","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Resverlogix (Canada)","funders":"National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences; National Institute on Aging","keywords":"Disease; Alzheimer's disease; Medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001023022,0.000215131,0.0005338627,0.00006977421,0.00005734682,0.000008931979,0.00008852661,0.00004443051,0.00005934714],"category_scores_gemma":[0.0001097729,0.0001326547,0.0001516301,0.000452417,0.0001058175,0.00002836036,0.00002315339,0.00008838223,0.00000699418],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002192641,"about_ca_system_score_gemma":0.0004777528,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007750767,"about_ca_topic_score_gemma":0.00003991105,"domain_scores_codex":[0.9985176,0.0001756009,0.0005116064,0.000376084,0.0001273526,0.000291789],"domain_scores_gemma":[0.9987434,0.000361396,0.0001310167,0.0004104384,0.0002631537,0.00009058193],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00311228,0.004419724,0.1228094,0.0003520601,0.0006323723,0.0005286824,0.001493765,0.00001972171,0.003459313,0.001170806,0.000428606,0.8615733],"study_design_scores_gemma":[0.004384219,0.002752368,0.4286078,0.0001053547,0.0007319411,0.00005609554,0.00003038916,0.00009214684,0.02601589,0.0001166721,0.5368677,0.0002394381],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8890025,0.10422,0.0000958666,0.004177881,0.0001876749,0.002220156,0.00002085357,0.000019727,0.00005530899],"genre_scores_gemma":[0.9819509,0.009254837,0.0003463403,0.006280123,0.0001794003,0.001679845,0.0001144969,0.00003754821,0.0001565233],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8613338,"threshold_uncertainty_score":0.5409502,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1204789983611148,"score_gpt":0.3635085386470207,"score_spread":0.2430295402859059,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}